Literature DB >> 15557584

Gonorrhea treatment guidelines in Canada: 2004 update.

Janice Mann1, Rhonda Kropp, Tom Wong, Sylvie Venne, Barbara Romanowski.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15557584      PMCID： PMC527333          DOI： 10.1503/cmaj.045088

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.

Authors:  Shelly Sarwal; Tom Wong; Cathy Sevigny; Lai-King Ng
Journal:  CMAJ       Date:  2003-04-01       Impact factor: 8.262

2.  Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.

Authors:  Lai-King Ng; Pamela Sawatzky; Irene E Martin; Stephanie Booth
Journal:  Sex Transm Dis       Date:  2002-12       Impact factor: 2.830

3.  Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-04-30       Impact factor: 17.586
  3 in total
  2 in total

1.  Treatment of septic arthritis.

Authors:  Cheryl Main
Journal:  CMAJ       Date:  2007-10-09       Impact factor: 8.262

2.  Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario.

Authors:  Kaede V Ota; Frances Jamieson; David N Fisman; Karen E Jones; Itamar E Tamari; Lai-King Ng; Lynn Towns; Prasad Rawte; Alessandro Di Prima; Tom Wong; Susan E Richardson
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.